DUBLIN–(BUSINESS WIRING) – The report “Amyotrophic Lateral Sclerosis – Global Market Trajectory and Analytics” was added to ResearchAndMarkets.com’s sentence.
Amid the COVID-19 crisis, the global amyotrophic lateral sclerosis market, estimated at US $ 339.2 million in 2020, is projected to reach a revised size of US $ 1.2 billion by 2027, with a CAGR of 19.2 % between 2020 and 2020. 2027 g.
The US market is estimated at $ 100.6 million, while China is forecast to grow 18.4% per year.
The US amyotrophic lateral sclerosis market is estimated at US $ 100.6 million in 2020. China, the world’s second largest economy, is projected to reach a projected market size of US $ 199.1 million by 2027, with a CAGR of 18.4%. the analysis period is from 2020 to 2027. Other notable geographic markets include Japan and Canada, each forecasting 17.1% and 16.5% growth, respectively, between 2020 and 2027. In Europe, Germany is projected to grow at an average annual rate of about 14.1%.
Select participants (31 favorites in total):
-
AB Science SA
-
Apotex, Inc.
-
Aquestive
-
Biogen, Inc.
-
Brainstorm Cell Therapeutics Inc.
-
Cytokinetics, Inc.
-
F. Hoffmann-La Roche AG
-
Genervon Biopharmaceuticals LLC
-
Ionis Pharmaceuticals, Inc.
-
Kringle Pharma Inc.
-
Mitsubishi Tanabe Pharma Corporation
-
Neuralstem, Inc.
-
Orion Corporation
-
Orphazim A / S
-
Sanofi S.A.
-
Treeway BV
-
Valeant Pharmaceuticals International, Inc.
-
ViroMed Co., Ltd.
Key Topics:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
-
Market influencers analysis
-
Trajectories of world markets
-
Impact of Covid-19 and the Looming Global Recession
III. MARKET ANALYSIS
IV. COMPETITION
-
Total companies represented: 31
For more information on this report, visit https://www.researchandmarkets.com/r/ay1mka.
Crude Oil May 21 
